Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Assets Average (2016 - 2026)

Usana Health Sciences has reported Assets Average over the past 16 years, most recently at $740.9 million for Q2 2026.

  • Quarterly Assets Average fell 0.86% to $740.9 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $740.9 million through Apr 2026, down 0.86% year-over-year, with the annual reading at $745.6 million for FY2026, 7.98% up from the prior year.
  • Assets Average was $740.9 million for Q2 2026 at Usana Health Sciences, up from $734.8 million in the prior quarter.
  • Over five years, Assets Average peaked at $747.4 million in Q1 2025 and troughed at $557.0 million in Q4 2022.
  • The 5-year median for Assets Average is $623.6 million (2023), against an average of $644.1 million.
  • Year-over-year, Assets Average dropped 6.1% in 2022 and then increased 18.44% in 2025.
  • A 5-year view of Assets Average shows it stood at $576.3 million in 2022, then increased by 7.05% to $617.0 million in 2023, then increased by 15.04% to $709.8 million in 2024, then rose by 2.93% to $730.6 million in 2025, then increased by 1.42% to $740.9 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Assets Average are $740.9 million (Q2 2026), $734.8 million (Q1 2026), and $730.6 million (Q3 2025).